Physician profile
Leno M Thomas
NPI 1093808370
$622.27
in general payments reported to CMS, 2019-2025
10 companies · $67.09 in 2025
The $67.09 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.24 · 2020: $18.57 · 2022: $154 · 2023: $150 · 2024: $182 · 2025: $67.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $159.35 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $154.68 | 2024 | |
| Baxter Healthcare | $109.00 | 2023-2024 | Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $49.57 | 2023-2025 | Smartvest |
| Glaxosmithkline, LLC. | $42.93 | 2022 | |
| Insmed, INC. | $29.45 | 2025 | Brinsupri |
| Regeneron Healthcare Solutions, INC. | $24.23 | 2019 | |
| Breas Medical, INC. | $18.79 | 2023 | Vivo 45 Ls |
| Novartis Pharmaceuticals Corporation | $18.57 | 2020 | |
| Amgen INC. | $15.70 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leno Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.